• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于尿路感染治疗中抗生素使用情况的调查。

Survey on antibiotic usage in the treatment of urinary tract infections.

作者信息

Naber K G

机构信息

Klinikum St Elisabeth Straubing GmbH, Germany.

出版信息

J Antimicrob Chemother. 2000 Sep;46 Suppl 1:49-52; discussion 63-5.

PMID:11051624
Abstract

Ninety-two clinical microbiologists, infectious disease clinicians and clinicians with an interest in the management of urinary tract infections (UTIs) participated in an interactive session concerning the management of acute uncomplicated lower UTI. The antibacterials considered most appropriate as first-line agents were trimethoprim, co-trimoxazole, pivmecillinam, nitrofurantoin and fluoroquinolones. The current level of usage of fluoroquinolones for lower UTIs was, however, considered inappropriate by most delegates from a 'societal perspective', in terms of spread of resistance and potential impact on the environment.

摘要

92名临床微生物学家、传染病临床医生以及对尿路感染(UTI)管理感兴趣的临床医生参加了一场关于急性单纯性下尿路感染管理的互动会议。被认为最适合作为一线药物的抗菌药物有甲氧苄啶、复方新诺明、匹美西林、呋喃妥因和氟喹诺酮类。然而,从“社会角度”来看,就耐药性传播和对环境的潜在影响而言,大多数代表认为目前氟喹诺酮类用于下尿路感染的使用水平是不合适的。

相似文献

1
Survey on antibiotic usage in the treatment of urinary tract infections.关于尿路感染治疗中抗生素使用情况的调查。
J Antimicrob Chemother. 2000 Sep;46 Suppl 1:49-52; discussion 63-5.
2
Survey on antibiotic usage in the treatment of urinary tract infections.关于尿路感染治疗中抗生素使用情况的调查。
J Antimicrob Chemother. 2000 Aug;46 Suppl A:49-52.
3
Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.缓释环丙沙星(Cipro XR)用于治疗尿路感染。
Int J Antimicrob Agents. 2004 Mar;23 Suppl 1:S54-66. doi: 10.1016/j.ijantimicag.2003.12.005.
4
Emerging drugs for bacterial urinary tract infections.新兴的治疗细菌性尿路感染的药物。
Expert Opin Emerg Drugs. 2010 Sep;15(3):375-97. doi: 10.1517/14728214.2010.500613.
5
Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years.
Int J Antimicrob Agents. 2005 Jul;26(1):75-7. doi: 10.1016/j.ijantimicag.2005.03.012.
6
[Impact of regional guidelines on the management of urinary tract infections with antibiotics].[区域指南对抗生素治疗尿路感染管理的影响]
Med Mal Infect. 2010 Jun;40(6):352-7. doi: 10.1016/j.medmal.2010.01.006. Epub 2010 Feb 20.
7
Emerging drugs for bacterial urinary tract infections.用于细菌性尿路感染的新型药物。
Expert Opin Emerg Drugs. 2005 May;10(2):275-98. doi: 10.1517/14728214.10.2.275.
8
Treatment options for acute uncomplicated cystitis in adults.成人急性单纯性膀胱炎的治疗选择。
J Antimicrob Chemother. 2000 Sep;46 Suppl 1:23-7; discussion 63-5.
9
Nitrofurantoin: the return of an old friend in the wake of growing resistance.呋喃妥因:在耐药性不断增加的情况下,一位老朋友的回归。
BJU Int. 2008 Dec;102(11):1634-7. doi: 10.1111/j.1464-410X.2008.07809.x. Epub 2008 Jul 24.
10
Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.土耳其儿童尿路感染尿路病原体的抗生素耐药性及经验性治疗评估
Int J Antimicrob Agents. 2006 Nov;28(5):413-6. doi: 10.1016/j.ijantimicag.2006.08.009. Epub 2006 Sep 26.

引用本文的文献

1
Prevalence and mechanism of fluoroquinolone resistance in clinical isolates of in Japan.日本临床分离株中氟喹诺酮耐药性的流行情况及机制
Heliyon. 2019 Mar 2;5(3):e01291. doi: 10.1016/j.heliyon.2019.e01291. eCollection 2019 Mar.
2
Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine.大肠埃希菌在尿液中生长时高水平美西林耐药性向敏感性的恢复。
EBioMedicine. 2017 Sep;23:111-118. doi: 10.1016/j.ebiom.2017.08.021. Epub 2017 Aug 24.
3
The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections - a randomized, double-blinded, placebo-controlled clinical trial study protocol.
匹美西林的疗效:每日三次给药,疗程3天或5天治疗社区获得性单纯性下尿路感染——一项随机、双盲、安慰剂对照临床试验研究方案
BMC Infect Dis. 2016 Dec 1;16(1):727. doi: 10.1186/s12879-016-2022-0.
4
A single center observational study on emergency department clinician non-adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infections.一项关于急诊科临床医生未遵循单纯性尿路感染治疗临床实践指南的单中心观察性研究。
BMC Infect Dis. 2016 Nov 4;16(1):638. doi: 10.1186/s12879-016-1972-6.